-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下:自动数据处理公司(ADP)公布了2026财年第三季度(截至6月)的强劲业绩,调整后每股收益为3.37美元(同比增长10%,高于市场预期2%),总营收为59亿美元(同比增长7%),超出预期9000万美元。业绩超预期主要得益于高效的运营执行和高收益客户基金投资额的增长。客户基金策略成为盈利增长的主要催化剂,基金利息收入飙升14%至4.04亿美元,这主要得益于平均账户余额增长9%至483亿美元以及收益率提升10个基点至3.3%。合并调整后息税前利润增长10%至18亿美元,利润率提升80个基点至30.2%,但各业务板块表现不一,其中雇主服务业务的利润率增幅显著。美国每控制权支付额增长稳定在1%,反映出宏观经济不确定性下企业持续保持招聘克制。我们认为,ADP拥有超过110万家公司的多元化客户群,能够有效抵御集中风险敞口。
Related Articles
Mizuho Securities Raises Price Target on Apellis Pharmaceuticals to $41 From $20, Maintains Neutral Rating
Apellis Pharmaceuticals (APLS) has an average rating of hold and mean price target of $40.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.95, Change: $-0.05, Percent Change: -0.11%
Mizuho Securities Downgrades Terns Pharmaceuticals to Neutral From Outperform, Trims Price Target to $53 From $54
Terns Pharmaceuticals (TERN) has an average rating of hold and mean price target of $53, according to analysts polled by FactSet.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Booking Holdings Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $8 to $196, 19x our 2026 EPS estimate (unchanged) and a discount to its 23x five-year average forward multiple, reflecting geopolitical risks. We lower our 2026 EPS to $10.33 from $10.74 and 2027's to $11.58 from $12.07, primarily reflecting lower gross bookings growth from the Middle East conflict. We maintain our Buy opinion as shares are undervalued given long-term competitive strengths and temporary geopolitical headwinds. The company's Connected Trip platform and Genius loyalty program are supporting higher-margin direct bookings, suggesting AI initiatives are strengthening consumer engagement rather than disintermediating the platform. Strong free cash flow supports future shareholder returns, including $3.6 billion in Q1 buybacks. While the Middle East conflict will impact Q2 bookings, BKNG has a history of seeing travel rebound following geopolitical or economic disruptions. U.S. room night growth accelerated in Q1 to a low-teens range, providing near-term momentum.